Sugarloaf Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-600
| Closed | -$33K | – | 839 |
|
|
2022
Q2 | $33K | Hold |
600
| – | – | 0.01% | 338 |
|
|
2022
Q1 | $33K | Hold |
600
| – | – | 0.01% | 332 |
|
|
2021
Q4 | $34K | Hold |
600
| – | – | 0.01% | 350 |
|
|
2021
Q3 | $29K | Hold |
600
| – | – | 0.01% | 353 |
|
|
2021
Q2 | $25K | Hold |
600
| – | – | 0.01% | 379 |
|
|
2021
Q1 | $20 | Hold |
600
| – | – | 0.01% | 404 |
|
|
2020
Q4 | $21K | Hold |
600
| – | – | 0.01% | 372 |
|
|
2020
Q3 | $21K | Hold |
600
| – | – | 0.01% | 347 |
|
|
2020
Q2 | $20K | Hold |
600
| – | – | 0.01% | 350 |
|
|
2020
Q1 | $18K | Hold |
600
| – | – | 0.01% | 350 |
|
|
2019
Q4 | $17K | Buy |
+600
| New | +$17K | 0.01% | 393 |
|